Open | - |
Close | - |
Volume / Avg. | 1.705K / 367.000K |
Day Range | - - - |
52 Wk Range | 0.418 - 4.400 |
Market Cap | $10.753M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 24 |
Short Interest | 3.05% |
Days to Cover | 1.45 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Longeveron (NASDAQ: LGVN) through any online brokerage.
Other companies in Longeveron’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Dominari Holdings (NASDAQ:DOMH), Imunon (NASDAQ:IMNN), Addex Therapeutics (NASDAQ:ADXN) and Monopar Therapeutics (NASDAQ:MNPR).
The latest price target for Longeveron (NASDAQ: LGVN) was reported by HC Wainwright & Co. on Monday, December 4, 2023. The analyst firm set a price target for 6.00 expecting LGVN to rise to within 12 months (a possible 1302.52% upside). 5 analyst firms have reported ratings in the last year.
The stock price for Longeveron (NASDAQ: LGVN) is $0.4278 last updated Today at March 19, 2024 at 6:19 AM EDT.
There are no upcoming dividends for Longeveron.
Longeveron’s Q1 earnings are confirmed for Friday, May 10, 2024.
There is no upcoming split for Longeveron.
Longeveron is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.